We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

News   Feb 22, 2013

 
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
 
 
 

RELATED ARTICLES

Peptide May Protect Kidneys From Ourselves

News

A synthetic peptide appears to directly disrupt the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain their important functions.

READ MORE

Male Birth Control Pill Passes Human Safety Tests

News

A new male birth control pill passed tests of safety and tolerability when healthy men used it daily for a month, and it produced hormone responses consistent with effective contraception, according to researchers at two institutions testing the drug.

READ MORE

Twin Registry Used to Reveal Autoimmune Drivers

News

Data from the world’s largest twin registry shows that the risk of developing seven autoimmune diseases is largely inherited, but that some diseases are more closely related than others.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE